Physician

Abdol A Mirsajadi, M.D.

According to 2025 Medicare claims, Abdol Mirsajadi, M.D. (NPI: 1235196080) practices psychiatry in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is ADULT & CHILD COUNSELING AND PSYCHIATRIC CENTER, P.A. (NPI: 1629034996; TIN: 593488333) and primary practice location at 32940-7323.

Mirsajadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 271 traditional Medicare patients, billed 820 HCPCS/CPT codes, and received $64,240 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 10,720 prescription claims across 541 beneficiaries totaling $431,947 in drug costs, led by Vraylar (Cariprazine Hcl). Open Payments data shows 6 records totaling $215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $392,597 and ending at $431,947. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$33K$66K2015 Medicare payment: $65,877 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $47,086 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $45,779 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $47,483 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $48,842 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $28,268 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $55,807 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $58,632 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $53,167 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $64,240 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153111,235$65,877
2016313852$47,086
2017314814$45,779
2018320818$47,483
2019305792$48,842
2020265509$28,268
2021222733$55,807
2022242822$58,632
2023228748$53,167
2024271820$64,240

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$276K$552K2015 Drug cost: $392,597 (USD; Tot_Drug_Cst)2016 Drug cost: $317,189 (USD; Tot_Drug_Cst)2017 Drug cost: $329,970 (USD; Tot_Drug_Cst)2018 Drug cost: $343,077 (USD; Tot_Drug_Cst)2019 Drug cost: $305,003 (USD; Tot_Drug_Cst)2020 Drug cost: $254,976 (USD; Tot_Drug_Cst)2021 Drug cost: $260,281 (USD; Tot_Drug_Cst)2022 Drug cost: $412,030 (USD; Tot_Drug_Cst)2023 Drug cost: $552,100 (USD; Tot_Drug_Cst)2024 Drug cost: $431,947 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154549,348$392,597
20164599,243$317,189
20174579,300$329,970
20184839,595$343,077
20194799,395$305,003
20204787,866$254,976
20213777,013$260,281
20224158,171$412,030
20234188,367$552,100
202454110,720$431,947

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90792Psychiatric diagnostic evaluation with medical services7474$144
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more129311$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more128435$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VraylarCariprazine Hcl661,924$96,799
IngrezzaValbenazine Tosylate11330$79,037
LybalviOlanzapine/Samidorphan Malate14420$20,587
VyvanseLisdexamfetamine Dimesylate441,306$16,992
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine43012,731$13,411

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$215Supernus Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdol A. Mirsajadi, M.D.?

Tedicare shows public-source Medicare data for Abdol A. Mirsajadi, M.D. (NPI 1235196080), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdol A. Mirsajadi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdol A. Mirsajadi, M.D.?

Abdol A. Mirsajadi, M.D. is linked to ADULT & CHILD COUNSELING AND PSYCHIATRIC CENTER, P.A. (billing NPI 1629034996) in the available physician profile data.

Does Abdol A. Mirsajadi, M.D. have Open Payments data?

Abdol A. Mirsajadi, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.